NCT04666389 The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases Status COMPLETED Phase NA
NCT04608344 Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants Status COMPLETED Phase PHASE1
NCT04591808 Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Status TERMINATED Phase PHASE3
NCT04575857 Role of Statins In Slowing Rheumatic Heart Disease (RHD) Progression Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04388501 A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants Status COMPLETED Phase PHASE1
NCT04375787 Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention Status COMPLETED Phase PHASE4
NCT04056039 Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis. Status COMPLETED Phase PHASE2
NCT03885921 Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019) Status COMPLETED Phase PHASE3
NCT03884452 Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018) Status COMPLETED Phase PHASE3
NCT03882996 A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032) Status COMPLETED Phase PHASE3
NCT03872388 Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy Status TERMINATED Phase PHASE2
NCT03867994 Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy. Status COMPLETED Phase PHASE2